论文部分内容阅读
盐酸决奈达隆(商品名Multaq)为苯并呋喃衍生物,具有不含碘的类似胺碘酮的化学结构,最初为法国赛诺菲-圣德拉堡集团开发的抗心律失常药。临床拟用于治疗房颤/房扑。决奈达隆2009年6月获FDA批准上市,在美国,自2009年6月至
Dronedarone hydrochloride (trade name Multaq) is a benzofuran derivative with a similar amiodarone-free chemical structure and was originally developed as an anti-arrhythmic drug by the Sanofi-Sardareaux Group of France. Clinical intended for the treatment of atrial fibrillation / atrial flutter. Dronedarone was approved by the FDA in June 2009 and is in the United States since June 2009